View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200 / Zanubrutinib 160, Chronic Lymphocytic Leukemia, Richter Transformation
Protocol-ID: 2840 V1.0 (Mini), TISL200/ZANU160, CLL (Richter Transformation)Indication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (Richter-Transformation, DLBCL); ICD-10 C91.1-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 11.03.2025